Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer
Year: 2025
Type: article
Language: en
Topic: Gut microbiota and health
Authors and affiliations:
raw_author_name: Yuri Yoshinami
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Shotaro Yamaguchi
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Hirokazu Shoji
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Natsuko Okita
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Hiroyuki Takamaru
raw_affiliation_strings: National Cancer Center Hospital
Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Toshiharu Hirose
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Hidekazu Hirano
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Atsuo Takashima
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Hiroshi Imazeki
raw_affiliation_strings: National Cancer Center Hospital
Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Shun Yamamoto
raw_affiliation_strings: National Cancer Center Hospital
Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: Shohei Koyama
raw_affiliation_strings: National Cancer Center
Department of Immuno Genomic Medicine, Research Institute, National Cancer Center, Tokyo, Japan
raw_author_name: Dai Ishikawa
raw_affiliation_strings: Juntendo University
Juntendo University School of Medicine
Metagen Therapeutics Inc
Research and Development Division, Metagen Therapeutics Inc., Yamagata, Japan
Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan
raw_author_name: Jun Terauchi
raw_affiliation_strings: Metagen Therapeutics Inc
Research and Development Division, Metagen Therapeutics Inc., Yamagata, Japan
raw_author_name: Kazuki Tanaka
raw_affiliation_strings: Metagen Therapeutics Inc
Research and Development Division, Metagen Therapeutics Inc., Yamagata, Japan
raw_author_name: Kana Ogawa
raw_affiliation_strings: Metagen Therapeutics Inc
Research and Development Division, Metagen Therapeutics Inc., Yamagata, Japan
raw_author_name: Hikaru Watanabe
raw_affiliation_strings: Metagen Therapeutics Inc
Research and Development Division, Metagen Therapeutics Inc., Yamagata, Japan
raw_author_name: Ken Kato
raw_affiliation_strings: National Cancer Center Hospital
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan